Skip to main content

93 B9 Pill - white capsule/oblong

Pill with imprint 93 B9 is White, Capsule/Oblong and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Teva Pharmaceuticals USA Inc.

Buprenorphine/naloxone is used in the treatment of Opioid Use Disorder and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 93 B9

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 2 mg (base) / 0.5 mg (base) 93 B9

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

93 B9
2 mg (base) / 0.5 mg (base)
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5720 (Discontinued)
Inactive Ingredients
acesulfame potassium, citric acid anhydrous, corn starch, lactose monohydrate, magnesium stearate, mannitol, povidone k30, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "93 B9"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.